Most strikingly, the microstructural alpha-globin gene mutation, included within the scope of clinically diagnosed anemia, was found to be harmful, accounting for 10-15% of ATR-X cases where microcytic anemia exists without structural alpha-thalassemia [2]. The gene discussed is HBA2; the disease is anemia (phenotype).